Alyeska Investment Group
RNA

Alyeska Investment Group’s PROSENSA HLDGS N V ORD SHS (NLD) RNA Stock Holding History

Alyeska Investment Group’s Portfolio RNA Stock Details RNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-50,000
Closed -$963K – 396
2013
Q2 		$963K Buy
+50,000
New +$963K 0.05% 244

Other funds holding RNA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Alyeska Investment Group's RNA Position: Q3 2013 in Review

Alyeska Investment Group sold out of PROSENSA HLDGS N V ORD SHS (NLD) (RNA) in Q3 2013, closing a stake of 50,000 shares — an estimated $963K sold.

Alyeska Investment Group first reported a position in RNA in Q2 2013 and held it in 1 quarter. The position peaked at $963K in Q2 2013. 26 funds tracked by Wall St. Rank hold RNA as of Q3 2013.

  • Alyeska Investment Group reported no remaining PROSENSA HLDGS N V ORD SHS (NLD) position as of Q3 2013 after selling out during the quarter.
  • Alyeska Investment Group sold 50,000 PROSENSA HLDGS N V ORD SHS (NLD) shares in Q3 2013, an estimated $963K.
  • Alyeska Investment Group first reported a position in PROSENSA HLDGS N V ORD SHS (NLD) in Q2 2013 and held it in 1 quarter.
  • Alyeska Investment Group's PROSENSA HLDGS N V ORD SHS (NLD) position peaked at $963K in Q2 2013.
  • 26 funds tracked by Wall St. Rank held PROSENSA HLDGS N V ORD SHS (NLD) as of Q3 2013.

Based on Alyeska Investment Group's 13F filing for Q3 2013, filed 14 Nov 2013.